Pure Squamous Cell Carcinoma of the Prostate With a Complete Remission to Gemcitabine-Cisplatin: Case Presentation and Literature Review
Abstract Squamous cell carcinoma of prostate is a very rare condition and little is known regarding the appropriate managment. Here we reported our patient with pure squamous cell carcinoma of prostate who had complete remission with gemcitabine and cisplatin treatment which last 5 months. Based on his genomic study of prostate cancer, he enrolled to our clinical trial and now receiveing mTOR pathway inhibtor. We also briefly reviewed previous cases of metastatic squamous cell carcinoma of prostate and their managment.
Authors
- Kevin Zarrabi (ORCID: https://orcid.org/0000-0002-9351-2317)
- William Tester (ORCID: https://orcid.org/0000-0002-5766-0195)
- Yang Yang (ORCID: https://orcid.org/0000-0001-6894-9341)
- Yilin Shen
- Yutao Deng
Institutions
- Johns Hopkins University (US)
- Thomas Jefferson University (US)
- Sidney Kimmel Cancer Center (US)
Publication Details
- Journal
- JU Open Plus
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1097/ju9.0000000000000215
- Citations
- 2
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.57